Location: Small Conference Hall of the Scientific Library, National Research Tomsk State University, Lenina, 34а.
Currently in Russia much effort by private companies, scientific organisations and state structures is focused on innovative drugs development. What will these efforts bring? Will Russian citizens become the main users of newly developed drugs or these drugs will also be available in the international market? Participants, whose expertise ranges from fundamental biological to such advanced stages of drug development as clinical trials, will discuss the goals of boosting innovative pharmaceuticals R&D in Russia; the new technologies used at each stage of drug R&D; the collaborations between stages of drug development; and the trajectories of Russian innovations in the world.
Oleg Melikhov, Candidate of Medical Sciences, Director of the Institute for Clinical Research, Chair of the Coordination Board of the League for Clinical Research Support.
Vladimir Chernov, Doctor of Medical Sciences, Professor, Vice-Chair of the Radionuclide Diagnostics Department, Tomsk Scientific Research Institute for Oncology.
Viktor Skuridin, Doctor of Technical Sciences, Professor, Head of the Nuclear Reactor Laboratory 31, Tomsk Polytechnic University.
Olga Vaisova, Doctor of Medical Sciences, Professor, Siberian State Medical University, Head of the working group for Strategic research programme of the Technology Platform ‘Medicine of the Future, Secretary to the Working Group on Federal Target Programme ‘Pharma-2020’.
Evgeny Denisov, Candidate of Biological Sciences, Senior Researcher, National Research Tomsk State University.
Veniamin Khazanov, Doctor of Medical Sciences, Professor, the Director of the drug R&D Centre IPHAR (CO., LTD), mentor in the ‘Skolkovo’ Biomedical cluster.
Evgenia Popova (PAST-Centre, National Research Tomsk State University, Russia)
Olga Zvonareva (Maastricht University, The Netherlands; PAST-Centre, National Research Tomsk State University, Russia).
For more information, please, visit the website of the Centre for Policy Analysis and Studies of Technologies; call +7 (3822) 535-602, or email: email@example.com